Zusammenfassung
The interaction of the steviol and its glycosides (SG), steviolbioside,
and rebaudioside A, with bovine serum albumin (BSA) was studied by
absorption and fluorescence spectroscopy techniques alongside molecular
docking. The stevia derivatives quenched the fluorescence of BSA by a
dynamic quenching mechanism, indicating the interaction between the
stevia derivatives and BSA. The binding constant (Kb) of steviol was
100-1000-fold higher than those of SG. The stevia derivative/BSA binding
reaction was spontaneous and involved the formation of hydrogen bonds
and van der Waals interactions between steviol and steviolbioside with
BSA, and water reorganization around the rebaudioside A/BSA complex.
Molecular docking pointed out the FA1 and FA9 binding sites of BSA as
the probable binding sites of steviol and SG, respectively. In
conclusion, steviol enhanced hydrophobicity and small size compared to
SG may favor its binding to BSA. As steviol and its glycosides share
binding sites on BSA with free fatty acids and drugs, they may be
competitively displaced from plasma albumin under various physiological
states or disease conditions. These findings are clinically relevant and
provide an insight into the pharmacokinetics and pharmacodynamics of the
stevia glycosides.
Nutzer